Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals.
作者信息
Shepshelovich Daniel, Yahav Dafna, Rome Danielle R, Goldvaser Hadar, Richter Ilan, Hermann Emilia A, Barr R Graham
机构信息
Department of Medicine, Columbia University Irving Medical Center, New York, New York.
Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.
出版信息
JAMA Intern Med. 2025 Apr 1;185(4):464-466. doi: 10.1001/jamainternmed.2024.7694.
Abstract
摘要
相似文献
1
Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals.发表于著名医学期刊的大型动脉粥样硬化性心血管疾病试验中主要结局的异质性。
JAMA Intern Med. 2025 Apr 1;185(4):464-466. doi: 10.1001/jamainternmed.2024.7694.
2
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准（CONSORT）以及医学期刊上发表的随机对照试验（RCT）的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
3
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施，以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
4
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
5
Chelation therapy for atherosclerotic cardiovascular disease.用于动脉粥样硬化性心血管疾病的螯合疗法。
Cochrane Database Syst Rev. 2002(4):CD002785. doi: 10.1002/14651858.CD002785.
6
Do peer reviewers comment on reporting items as instructed by the journal? A secondary analysis of two randomized trials.同行评审员是否按照期刊的要求对报告项目进行评论？两项随机试验的二次分析。
J Clin Epidemiol. 2025 May 8;183:111818. doi: 10.1016/j.jclinepi.2025.111818.
7
Meditation for the primary and secondary prevention of cardiovascular disease.冥想用于心血管疾病的一级和二级预防。
Cochrane Database Syst Rev. 2024 Feb 15;2(2):CD013358. doi: 10.1002/14651858.CD013358.pub2.
8
Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals.随机对照试验的报告是否随着时间的推移而有所改善？对发表在高影响力的普通医学和专业医学期刊上的 284 篇文章的系统评价。
PLoS One. 2013 Dec 31;8(12):e84779. doi: 10.1371/journal.pone.0084779. eCollection 2013.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力：系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
本文引用的文献
1
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.在肾脏病和 2 型糖尿病患者中用非奈利酮发生的心血管事件。
N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28.
2
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
3
Composite End Points in Clinical Research: A Time for Reappraisal.临床研究中的复合终点：重新评估的时刻。
Circulation. 2017 Jun 6;135(23):2299-2307. doi: 10.1161/CIRCULATIONAHA.117.026229.
4
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.从方案到发表：肿瘤学随机试验中结果选择性报告的一项研究
J Clin Oncol. 2015 Nov 1;33(31):3583-90. doi: 10.1200/JCO.2015.62.4148. Epub 2015 Aug 24.
5
Composite outcomes in randomized trials: greater precision but with greater uncertainty?随机试验中的复合结局：更高的精确性但伴随着更大的不确定性？
JAMA. 2003 May 21;289(19):2554-9. doi: 10.1001/jama.289.19.2554.
Zotero 插件